share_log

Ademi LLP Investigates Claims of Securities Fraud Against Akero Therapeutics, Inc.

Ademi LLP Investigates Claims of Securities Fraud Against Akero Therapeutics, Inc.

Ademi LLP调查针对Akero Therapeutics, Inc.的证券欺诈指控
PR Newswire ·  04/02 18:05

MILWAUKEE, April 2, 2024 /PRNewswire/ -- Ademi LLP is investigating possible securities fraud claims against Akero (Nasdaq: AKRO). The investigation results from inaccurate statements Akero may have made regarding its business operations and prospects.

密尔沃基,2024年4月2日 /PRNewswire/ — Ademi LLP正在调查可能针对Akero(纳斯达克股票代码:AKRO)的证券欺诈指控。调查源于Akero可能就其业务运营和前景发表的不准确陈述。

Click here to learn more about the investigation: or call Guri Ademi toll-free at 866-264-3995. There is no cost or obligation to you.

点击此处了解有关调查的更多信息:或拨打古里·阿德米的免费电话866-264-3995。您无需承担任何费用或义务。

The investigation focuses on Akero's representations regarding its Phase 2b clinical study evaluating efruxifermin (EFX) in treating patients with compensated cirrhosis due to nonalcoholic steatohepatitis (NASH). In October 2023, Akero reported that 22% of patients receiving a lower dose of EFX and 24% of patients receiving a higher dose experienced an improvement of at least one stage in liver fibrosis with no worsening of NASH by week 36. However, this improvement wasn't statistically significant compared to the results for placebo.

该调查的重点是Akero对其2b期临床研究的陈述,该研究评估了依氟西弗明(EFX)治疗非酒精性脂肪肝炎(NASH)引起的代偿性肝硬化患者。2023年10月,Akero报告称,在接受较低剂量EFX的患者中,有22%和接受更高剂量的患者中,有24%的肝纤维化在第36周之前改善了至少一个阶段,NASH没有恶化。但是,与安慰剂的结果相比,这种改善在统计学上并不显著。

If you wish to obtain additional information or have information about this investigation, please contact Guri Ademi either at [email protected] or toll-free: 866-264-3995,

如果你想获得更多信息或了解有关本次调查的信息,请致电 [email protected] 或免费电话:866-264-3995 与 Guri Ademi 联系,

We specialize in securities fraud and shareholder litigation. For more information, please feel free to call us. Attorney advertising. Prior results do not guarantee similar outcomes.

我们专门从事证券欺诈和股东诉讼。欲了解更多信息,请随时致电我们。律师广告。先前的结果并不能保证类似的结果。

Contact:
Ademi LLP
Guri Ademi
3620 East Layton Ave.
Cudahy, WI 53110
Toll Free: (866) 264-3995
Fax: (414) 482-8001

联系人:
Ademi LLP
Guri Ademi
东雷顿大道 3620 号
威斯康星州库达希 53110
免费电话:(866) 264-3995
传真:(414) 482-8001

SOURCE Ademi LLP

来源 Ademi LLP

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发